Gold Falls Amid Dollar Strength, Signs of Easing U.S.-China Trade Tensions
2347 GMT — Gold falls in the early morning Asian session amid dollar strength, which tends to make the precious metal more expensive for investors holding other currencies. Also, signs of easing U.S.-China trade tensions may have reduced gold's safe-haven appeal. The WSJ reported that China has exempted some U.S. imports that the country would struggle to immediately source from elsewhere from its retaliatory tariffs. Market sentiment has shifted as the dollar stabilizes and traders have started to reassess risks surrounding trade tensions, FFA Kings' founder and CEO Fadi Al Kurdi says in an email. Spot gold is 0.4% lower at $3,306.73/oz. (ronnie.harui@wsj.com)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
Asian Market Insights: Guangshen Railway And 2 Other Penny Stocks To Watch
As the Asian markets navigate a complex landscape of global trade tensions and economic shifts, investors are increasingly turning their attention to smaller companies that may offer unique opportunities. Penny stocks, though an older term, still represent a segment of the market where emerging or less-established firms can provide potential value. By focusing on those with strong financials and growth prospects, these stocks can present intriguing possibilities for investors looking to explore under-the-radar opportunities in Asia. Name Share Price Market Cap Financial Health Rating YKGI (Catalist:YK9) SGD0.10 SGD42.5M ★★★★★★ Lever Style (SEHK:1346) HK$1.15 HK$725.59M ★★★★★★ TK Group (Holdings) (SEHK:2283) HK$2.10 HK$1.75B ★★★★★★ CNMC Goldmine Holdings (Catalist:5TP) SGD0.425 SGD172.25M ★★★★★☆ Goodbaby International Holdings (SEHK:1086) HK$1.18 HK$1.97B ★★★★★★ Halcyon Technology (SET:HTECH) THB2.64 THB792M ★★★★★★ Yangzijiang Shipbuilding (Holdings) (SGX:BS6) SGD2.28 SGD8.97B ★★★★★☆ Beng Kuang Marine (SGX:BEZ) SGD0.179 SGD35.66M ★★★★★★ BRC Asia (SGX:BEC) SGD3.12 SGD855.97M ★★★★★★ Bosideng International Holdings (SEHK:3998) HK$4.52 HK$51.78B ★★★★★★ Click here to see the full list of 1,147 stocks from our Asian Penny Stocks screener. Here we highlight a subset of our preferred stocks from the screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Guangshen Railway Company Limited operates in the railway passenger and freight transportation sectors in the People's Republic of China, with a market cap of HK$20.93 billion. Operations: The company generates revenue of CN¥27.39 billion from its operations in China. Market Cap: HK$20.93B Guangshen Railway's recent performance highlights a stable revenue stream, with Q1 2025 sales reaching CN¥6.90 billion, up from the previous year. Despite this growth, net income declined to CN¥468.18 million from CN¥546.94 million, reflecting a dip in profit margins from 4.5% to 3.6%. The company maintains strong financial health with more cash than total debt and robust interest coverage at 31.7x EBIT. However, earnings growth has been negative over the past year at -18.2%, underperforming the industry average of 2.7%. The stock trades significantly below its estimated fair value but has an unstable dividend history. Click here and access our complete financial health analysis report to understand the dynamics of Guangshen Railway. Examine Guangshen Railway's earnings growth report to understand how analysts expect it to perform. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Ming Yuan Cloud Group Holdings Limited is an investment holding company that offers cloud services and on-premises software in China, with a market cap of approximately HK$5.16 billion. Operations: The company's revenue is primarily derived from Cloud Services, which generated CN¥1.20 billion, and On-premise Software and Services, contributing CN¥239.73 million. Market Cap: HK$5.16B Ming Yuan Cloud Group Holdings, despite being unprofitable with a net loss of CN¥189.55 million for 2024, shows financial resilience through its substantial short-term assets of CN¥4.1 billion, which cover both short and long-term liabilities comfortably. The company is debt-free and has maintained a sufficient cash runway for over three years based on current free cash flow. While the stock trades below its estimated fair value, it has an unstable dividend track record but recently announced a special dividend of HK$0.1 per share to shareholders, showcasing shareholder returns amidst ongoing challenges in profitability growth. Jump into the full analysis health report here for a deeper understanding of Ming Yuan Cloud Group Holdings. Evaluate Ming Yuan Cloud Group Holdings' prospects by accessing our earnings growth report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Jiumaojiu International Holdings Limited operates and manages Chinese cuisine restaurant brands across several countries including China, Singapore, Canada, Malaysia, Thailand, the United States, and Indonesia with a market cap of HK$3.54 billion. Operations: The company's revenue is primarily derived from its Tai Er segment, contributing CN¥4.41 billion, followed by Jiu Mao Jiu with CN¥546.18 million and Song Hot Pot with CN¥894.97 million. Market Cap: HK$3.54B Jiumaojiu International Holdings, with a market cap of HK$3.54 billion, has shown financial stability by maintaining more cash than its total debt and having short-term assets of CN¥2.3 billion that exceed both short and long-term liabilities. Despite a significant one-off loss impacting earnings, the company reported revenues primarily from its Tai Er segment at CN¥4.41 billion for 2024. Recent corporate actions include declaring a special dividend of HKD 0.02 per share despite reduced net profit margins to 0.9% from the previous year's 7.6%, reflecting ongoing profitability challenges amidst strategic shareholder returns initiatives. Dive into the specifics of Jiumaojiu International Holdings here with our thorough balance sheet health report. Assess Jiumaojiu International Holdings' future earnings estimates with our detailed growth reports. Discover the full array of 1,147 Asian Penny Stocks right here. Ready To Venture Into Other Investment Styles? Uncover 18 companies that survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include SEHK:525 SEHK:909 and SEHK:9922. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
44 minutes ago
- Yahoo
Asian Dividend Stocks To Watch In 2023
As global markets navigate a complex landscape of trade tensions and economic shifts, Asian indices have shown resilience, with Chinese stocks gaining momentum amid expectations of government stimulus. In this environment, dividend stocks in Asia present an intriguing opportunity for investors seeking steady income streams, particularly as companies with strong fundamentals and reliable payout histories can offer stability amidst market fluctuations. Name Dividend Yield Dividend Rating Yamato Kogyo (TSE:5444) 4.44% ★★★★★★ Wuliangye YibinLtd (SZSE:000858) 5.07% ★★★★★★ Nissan Chemical (TSE:4021) 4.20% ★★★★★★ Japan Excellent (TSE:8987) 4.39% ★★★★★★ HUAYU Automotive Systems (SHSE:600741) 4.50% ★★★★★★ Guangxi LiuYao Group (SHSE:603368) 4.42% ★★★★★★ DoshishaLtd (TSE:7483) 4.18% ★★★★★★ Daicel (TSE:4202) 5.01% ★★★★★★ CAC Holdings (TSE:4725) 4.87% ★★★★★★ Asian Terminals (PSE:ATI) 6.37% ★★★★★★ Click here to see the full list of 1240 stocks from our Top Asian Dividend Stocks screener. Here's a peek at a few of the choices from the screener. Simply Wall St Dividend Rating: ★★★★☆☆ Overview: GS Holdings Corp., along with its subsidiaries, operates in the energy, power generation, retail, service, construction, and infrastructure sectors with a market cap of ₩4.49 trillion. Operations: GS Holdings Corp.'s revenue primarily comes from its Distribution segment at ₩11.39 trillion, followed by the Gas and Electric Business at ₩7.43 trillion, Trade at ₩3.91 trillion, with an adjustment for Cross-Sector Revenue of -₩0.21 trillion. Dividend Yield: 5.7% GS Holdings offers a compelling dividend profile with its payouts well-covered by earnings (63.7% payout ratio) and cash flows (47.4% cash payout ratio). The dividend yield of 5.68% ranks in the top 25% of South Korean market payers, though the company has only a three-year history of dividends, indicating limited track record stability. Despite recent profit margin declines, GS Holdings trades at a significant discount to fair value estimates and peers, enhancing its attractiveness as a value investment. Take a closer look at GS Holdings' potential here in our dividend report. Our valuation report here indicates GS Holdings may be undervalued. Simply Wall St Dividend Rating: ★★★★☆☆ Overview: Shandong Weigao Group Medical Polymer Company Limited is involved in the R&D, production, wholesale, and sale of medical devices both in China and internationally, with a market cap of HK$26.97 billion. Operations: Shandong Weigao Group Medical Polymer's revenue is primarily derived from its Medical Device Products segment at CN¥6.60 billion, followed by Interventional Products at CN¥1.98 billion, Pharma Packaging Products at CN¥2.28 billion, Orthopaedic Products at CN¥1.44 billion, and Blood Management Products at CN¥876.78 million. Dividend Yield: 4% Shandong Weigao Group Medical Polymer provides a mixed dividend profile, with payouts covered by earnings (47.3% payout ratio) and cash flows (45.9% cash payout ratio), yet its dividend history has been volatile over the past decade. Recent shareholder-approved buybacks aim to enhance net asset value and earnings per share, potentially bolstering future dividends. The company trades at a considerable discount to fair value estimates, though its current yield of 3.98% lags behind top-tier payers in Hong Kong. Click here and access our complete dividend analysis report to understand the dynamics of Shandong Weigao Group Medical Polymer. Our valuation report unveils the possibility Shandong Weigao Group Medical Polymer's shares may be trading at a discount. Simply Wall St Dividend Rating: ★★★★☆☆ Overview: Dongfang Electric Corporation Limited designs, develops, manufactures, and sells power generation equipment in China and internationally with a market cap of HK$60.10 billion. Operations: Dongfang Electric Corporation Limited's revenue segments include CN¥45.23 billion from thermal power equipment, CN¥12.78 billion from hydropower equipment, CN¥5.67 billion from wind power equipment, and CN¥3.45 billion from nuclear power equipment. Dividend Yield: 3.6% Dongfang Electric's dividends are supported by earnings (43.1% payout ratio) and cash flows (59.2% cash payout ratio), though its dividend history has been unstable over the last decade. Recent earnings reports show improved financial performance, with Q1 2025 net income rising to CNY 1.15 billion from CNY 905.75 million a year earlier, yet the proposed final dividend for 2024 decreased, reflecting ongoing volatility in payouts despite potential growth prospects. Get an in-depth perspective on Dongfang Electric's performance by reading our dividend report here. The valuation report we've compiled suggests that Dongfang Electric's current price could be inflated. Take a closer look at our Top Asian Dividend Stocks list of 1240 companies by clicking here. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. Find companies with promising cash flow potential yet trading below their fair value. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include KOSE:A078930 SEHK:1066 and SEHK:1072. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Asian Value Stocks Estimated Below Intrinsic Worth
As global markets navigate a complex landscape, the Asian financial scene is drawing attention with its potential for value investing, particularly as China's economic indicators suggest room for further stimulus and Japan's moderate recovery continues. In this environment, identifying stocks that are trading below their intrinsic worth can be an effective strategy, offering opportunities to capitalize on market inefficiencies while mitigating risk through thorough analysis. Name Current Price Fair Value (Est) Discount (Est) Wenzhou Yihua Connector (SZSE:002897) CN¥38.99 CN¥76.64 49.1% Taiyo Yuden (TSE:6976) ¥2411.50 ¥4741.52 49.1% Livero (TSE:9245) ¥1692.00 ¥3352.54 49.5% Kanto Denka Kogyo (TSE:4047) ¥841.00 ¥1677.13 49.9% Hangzhou Zhongtai Cryogenic Technology (SZSE:300435) CN¥16.67 CN¥33.21 49.8% Gushengtang Holdings (SEHK:2273) HK$38.35 HK$76.50 49.9% Fuji (TSE:6134) ¥2253.50 ¥4448.27 49.3% Everest Medicines (SEHK:1952) HK$54.55 HK$107.01 49% Brangista (TSE:6176) ¥597.00 ¥1180.86 49.4% Boditech Med (KOSDAQ:A206640) ₩15850.00 ₩31439.92 49.6% Click here to see the full list of 302 stocks from our Undervalued Asian Stocks Based On Cash Flows screener. Below we spotlight a couple of our favorites from our exclusive screener. Overview: Yuhan Corporation is a South Korean company that manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods both domestically and internationally, with a market cap of ₩8.04 trillion. Operations: The company's revenue segments include biotechnology startups, which contribute ₩2.11 billion to its overall earnings. Estimated Discount To Fair Value: 22.4% Yuhan's current trading price of ₩107,300 is significantly below its estimated fair value of ₩138,269.28, suggesting it may be undervalued based on cash flows. Despite a forecasted 44% annual earnings growth outpacing the Korean market average, recent financials show declining profit margins and net income compared to the previous year. The company has engaged in substantial share buybacks over time but reported no repurchases in early 2025. Our comprehensive growth report raises the possibility that Yuhan is poised for substantial financial growth. Click here and access our complete balance sheet health report to understand the dynamics of Yuhan. Overview: ASMPT Limited is an investment holding company that designs, manufactures, and markets machines, tools, and materials for the semiconductor and electronics assembly industries globally, with a market cap of HK$23.74 billion. Operations: The company's revenue is primarily derived from its Semiconductor Solutions segment, which generated HK$7.42 billion, and its Surface Mount Technology (SMT) Solutions segment, contributing HK$5.79 billion. Estimated Discount To Fair Value: 41.9% ASMPT's current trading price of HK$57 is significantly below its estimated fair value of HK$98.04, highlighting potential undervaluation based on cash flows. Despite a decrease in profit margins and net income compared to the previous year, ASMPT anticipates revenue growth between US$410 million and US$470 million for Q2 2025, driven by seasonal factors and strong bookings. The company declared a special dividend of HKD 0.25 per share but reduced its final dividend to HKD 0.07 per share for 2024. The analysis detailed in our ASMPT growth report hints at robust future financial performance. Get an in-depth perspective on ASMPT's balance sheet by reading our health report here. Overview: Accton Technology Corporation is engaged in the research, development, manufacturing, and sale of network communication equipment across Taiwan, America, Asia, Europe, and other international markets with a market cap of NT$411.92 billion. Operations: The company's revenue primarily comes from its Computer Networks segment, which generated NT$134.33 billion. Estimated Discount To Fair Value: 33.9% Accton Technology's current trading price of NT$737 is substantially below its estimated fair value of NT$1115.68, suggesting undervaluation based on cash flows. The company reported significant earnings growth for Q1 2025, with net income rising to TWD 5.13 billion from TWD 2.24 billion a year earlier. Despite high non-cash earnings, Accton's projected revenue and profit growth rates exceed Taiwan's market averages, indicating robust future performance potential despite moderate annual profit growth forecasts. Our earnings growth report unveils the potential for significant increases in Accton Technology's future results. Click to explore a detailed breakdown of our findings in Accton Technology's balance sheet health report. Access the full spectrum of 302 Undervalued Asian Stocks Based On Cash Flows by clicking on this link. Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes. Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage. Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include KOSE:A000100 SEHK:522 and TWSE:2345. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
